Fate Therapeutics announces issuance of U.S. patent on compositions of human iPSCs
Fate Therapeutics announced the USPTO issued U.S. Patent No. 9,382,515 covering preparations of human induced pluripotent cells. This newly-issued patent adds to their IP portfolio of over 60 issued patents and 90 pending applications, which are owned or exclusively licensed by the company. July 26, 2016